Constructive Bio appoints biopharma leader Jim Weissman to its Board of Directors
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
Constructive Bio Partners with RxCelerate to Advance ncAA-Containing Biologics Through Drug Design and Development
Constructive Bio and RxCelerate have partnered to combine programmable biology and ncAA-enabled protein engineering with drug design and development capabilities,…
Constructive Bio Founder and Chief Scientific Officer, Professor Jason Chin, named the 2026 Heinrich Wieland Prize recipient
Constructive Bio founder and CSO Professor Jason Chin received the SynBioBeta 2025 Impact Award, recognising his contributions to synthetic biology…
